MedPath

The effect of Mg on the cardiac biomarker proBNP

Phase 2
Completed
Conditions
Atherosclerotic heart disease.
Atherosclerotic heart disease
Registration Number
IRCT201205069650N1
Lead Sponsor
Anesthesiology Research Center, Shahid Beheshtil Universityof medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

significant coronary artery stenosis (2VD or 3VD) and EF<45%. Exclusion criteria: 1.Conduction abnormality (branch block); 2.AF rhythm; 3.Diabetes mellitus. 4.cr>1.8; 5.Emergent surgery; 6.Unstable angina; 7.Redo surgery; 8.Combination surgery (carotid endarterectomy, vulvoplasty); 9.long QT syndrome, neuromuscular junction disorders.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ProBNP. Timepoint: before intervention, 24 hours after intervention. Method of measurement: ELISA based lab kit.
Secondary Outcome Measures
NameTimeMethod
Mechanical ventilation time. Timepoint: days on mechanical ventilation. Method of measurement: questionnaire.
© Copyright 2025. All Rights Reserved by MedPath